医学
托法替尼
贾纳斯激酶
黑匣子
鲁索利替尼
类风湿性关节炎
药理学
内科学
受体
骨髓纤维化
计算机科学
人工智能
骨髓
作者
Yekaterina Tokareva,Pankti Reid,Victor Yang,David Liew,Alexander C. Peterson,Aaron Baraff,Jon T. Giles,Namrata Singh
标识
DOI:10.1080/1744666x.2023.2249237
摘要
Janus kinase inhibitors (JAKi) have dramatically improved the treatment of various autoimmune and myeloproliferative disorders. Recently, concern has arisen regarding their safety in patients with rheumatoid arthritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI